The COVID-19 Green Certificate's Effect on Vaccine Uptake in French and Italian Regions

Overview

Journal J Policy Model

Date 2024 Apr 15

PMID 38620110

Authors

Raffaella Santolini

Affiliations

Soon will be listed here.

Abstract

The COVID-19 green certificates were introduced in many countries in 2021 to encourage vaccine uptake against the COVID-19 virus in order to reduce the spread of severe infection among the population, ensure the safety of cross-border movements, and facilitate the resumption of social life and economic activities. This study uses a single-group interrupted time series approach to examine the effect of the green certificate announcement on the first doses of the COVID-19 vaccine in 20 Italian and 18 French regions during the summer of 2021. The estimation results show that the green certificate announcement mitigated regional disparities in vaccine uptake. It persuaded undecided people to have their first doses of the COVID-19 vaccine, especially in regions lagging in the mass vaccination campaign. It was less effective in those regions where there was already a high level of vaccine protection. The announcement also proved to be an effective political strategy with which to increase the first-dose rates immediately, but not in the long term.

References

Oliu-Barton M, Pradelski B, Woloszko N, Guetta-Jeanrenaud L, Aghion P, Artus P . The effect of COVID certificates on vaccine uptake, health outcomes, and the economy. Nat Commun. 2022; 13(1):3942. PMC: 9263819. DOI: 10.1038/s41467-022-31394-1. View

Linden A, Yarnold P . Using machine learning to identify structural breaks in single-group interrupted time series designs. J Eval Clin Pract. 2016; 22(6):851-855. DOI: 10.1111/jep.12544. View

Karaivanov A, Kim D, Lu S, Shigeoka H . COVID-19 vaccination mandates and vaccine uptake. Nat Hum Behav. 2022; 6(12):1615-1624. DOI: 10.1038/s41562-022-01363-1. View

Linden A, Adams J . Applying a propensity score-based weighting model to interrupted time series data: improving causal inference in programme evaluation. J Eval Clin Pract. 2010; 17(6):1231-8. DOI: 10.1111/j.1365-2753.2010.01504.x. View

Beccia F, Di Pilla A, Causio F, Federico B, Specchia M, Favaretti C . Narrative Review of the COVID-19 Pandemic's First Two Years in Italy. Int J Environ Res Public Health. 2022; 19(23). PMC: 9736498. DOI: 10.3390/ijerph192315443. View

Merkaj E, Santolini R . Italian national policies in response to the COVID-19 pandemic: The case of the Friuli-Venezia-Giulia and Umbria Regions. Health Policy. 2022; 126(4):287-293. PMC: 8874741. DOI: 10.1016/j.healthpol.2022.02.004. View

Walkowiak M, Walkowiak J, Walkowiak D . COVID-19 Passport as a Factor Determining the Success of National Vaccination Campaigns: Does It Work? The Case of Lithuania vs. Poland. Vaccines (Basel). 2021; 9(12). PMC: 8708167. DOI: 10.3390/vaccines9121498. View

Ward J, Gauna F, Gagneux-Brunon A, Botelho-Nevers E, Cracowski J, Khouri C . The French health pass holds lessons for mandatory COVID-19 vaccination. Nat Med. 2022; 28(2):232-235. DOI: 10.1038/s41591-021-01661-7. View

Hudson J, Fielding S, Ramsay C . Methodology and reporting characteristics of studies using interrupted time series design in healthcare. BMC Med Res Methodol. 2019; 19(1):137. PMC: 6609377. DOI: 10.1186/s12874-019-0777-x. View

10.

Mills M, Ruttenauer T . The effect of mandatory COVID-19 certificates on vaccine uptake: synthetic-control modelling of six countries. Lancet Public Health. 2021; 7(1):e15-e22. PMC: 8668192. DOI: 10.1016/S2468-2667(21)00273-5. View

11.

Wise J . Covid-19: France and Greece make vaccination mandatory for healthcare workers. BMJ. 2021; 374:n1797. DOI: 10.1136/bmj.n1797. View

12.

Chevreul K, Durand-Zaleski I, Bahrami S, Hernandez-Quevedo C, Mladovsky P . France: Health system review. Health Syst Transit. 2011; 12(6):1-291, xxi-xxii. View

13.

Drury J, Mao G, John A, Kamal A, James Rubin G, Stott C . Behavioural responses to Covid-19 health certification: a rapid review. BMC Public Health. 2021; 21(1):1205. PMC: 8221819. DOI: 10.1186/s12889-021-11166-0. View

14.

Waitzberg R, Triki N, Alroy-Preis S, Lotan T, Shiran L, Ash N . The Israeli Experience with the "Green Pass" Policy Highlights Issues to Be Considered by Policymakers in Other Countries. Int J Environ Res Public Health. 2021; 18(21). PMC: 8582817. DOI: 10.3390/ijerph182111212. View

15.

Bernal J, Cummins S, Gasparrini A . Interrupted time series regression for the evaluation of public health interventions: a tutorial. Int J Epidemiol. 2016; 46(1):348-355. PMC: 5407170. DOI: 10.1093/ije/dyw098. View

16.

Berardi C, Antonini M, Genie M, Cotugno G, Lanteri A, Melia A . The COVID-19 pandemic in Italy: Policy and technology impact on health and non-health outcomes. Health Policy Technol. 2020; 9(4):454-487. PMC: 7467905. DOI: 10.1016/j.hlpt.2020.08.019. View

17.

Montanari Vergallo G, Rio A, Negro F, Zaami S . COVID-19 vaccine mandates: what are the current European public perspectives?. Eur Rev Med Pharmacol Sci. 2022; 26(2):643-652. DOI: 10.26355/eurrev_202201_27891. View

18.

Ferre F, de Belvis A, Valerio L, Longhi S, Lazzari A, Fattore G . Italy: health system review. Health Syst Transit. 2014; 16(4):1-168. View

19.

Desson Z, Weller E, McMeekin P, Ammi M . An analysis of the policy responses to the COVID-19 pandemic in France, Belgium, and Canada. Health Policy Technol. 2021; 9(4):430-446. PMC: 7832234. DOI: 10.1016/j.hlpt.2020.09.002. View

20.

Antonini M, Eid M, Falkenbach M, Rosenbluth S, Arija Prieto P, Brammli-Greenberg S . An analysis of the COVID-19 vaccination campaigns in France, Israel, Italy and Spain and their impact on health and economic outcomes. Health Policy Technol. 2022; 11(2):100594. PMC: 8702636. DOI: 10.1016/j.hlpt.2021.100594. View